What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2026-08-19 compared with 2026-05-20 · 51 added, 88 removed, 174 unchanged (44% of the section changed)

OTHER INFORMATION

Astor Forbearance Agreement

On March 17, 2025, the Company issued a junior secured convertible promissory note (the “Initial Note”) to J.J.

(the “Lender”), in the principal amount of $6,625,000 (the “Principal Amount”), in relation to a Loan and Security Agreement by and between the Company, its subsidiaries, and the Lender (the “Loan Agreement”).

The Company received $5,000,000, before fees.

The Company received the funds on March 18, 2025.

In relation to the Loan Agreement, the Company also entered into a Registration Rights Agreement with the Lender (the “RRA”), under which the Company was obligated to file a resale registration statement with the SEC registering any shares of its common stock issuable under the Note no later than sixty (60) days after closing.

The information regarding this transaction was filed in a Current Report on Form 8-K filed with the Commission on March 21, 2025.

As previously reported, on July 9, 2025, the Company entered into a Forbearance and Amendment to Loan Agreement and Note, which amended the terms of the Loan Agreement, Initial Note and RRA (the “First Forbearance Agreement”).

Under the terms of the First Forbearance Agreement, the Lender agreed to loan us additional funds under a Second Junior Secured Promissory Note (the “Second Note”) and agreed to forbear any default under the Initial Note in exchange for certain consideration.

The information regarding this transaction was filed in a Current Report on Form 8-K filed with the Commission on July 21, 2025.

On October 8, 2025, the Company entered into a Second Forbearance and Amendment to Loan Agreement and Notes, which amended the terms of the Loan Agreement, Initial Note, the RRA, the Second Note and the First Forbearance Agreement (the “Second Forbearance Agreement”).

Under the terms of the Second Forbearance Agreement:

(i) the Lender agreed to loan us an additional amount up to $2,450,000, (ii) the Outstanding Principal Amount of the Initial Note was $2,259,319.89 and the Outstanding Principal Balance on the Second Note was $5,685,805.13 on the Forbearance Agreement Effective Date, (iii) the Lender provided notice of default to the Company under the Second Note, thereby accelerating all amounts due thereunder, (iv) the Lender agreed the Company was not in default of the Initial Note, Second Note or other Transaction Documents effective September 30, 2025 and to forbear declaring an Event of Default going forward and accelerating all amounts due under the Initial Note and the Second Note, subject to the Company complying with the terms of the Second Forbearance Agreement, (v) all amounts due under the Initial Note and the Second Note, with any accrued interest, will be due on or before November 30, 2025, (vi) interest under the Initial Note and Second Note will continue at the default interest rate of 19%, (vii) the conversion terms under the Initial Note and Second Note will remain on the Default Conversion Price under those instruments, and (viii) the Lender agreed to a standstill period until November 30, 2025, during which time the Lender will not declare an event of default or accelerate any payment obligations under the Initial Note or the Second Note, so long as the Company (a) pays interest at the Default Interest Rate on the Initial Note and the Second Note, (b) issues the Third Note to the Lender, and (c) pays in full all past due payments on the Initial Note and the Second Note on or before November 30, 2025.

In connection with the Second Forbearance Agreement the Lender agreed to loan the Company up to an additional $2,450,000.

On October 9, 2025, the Company and Lender entered into an Additional Junior Secured Convertible Note (the “Third Note”), under which the Company agreed to issue the Lender the Third Note in the principal amount of $1,620,000, with the Company receiving proceeds of $1,152,000 before subtracting $53,000 for legal fees and origination fees.

The Company received the first funds from the Third Note on October 9, 2025 with the remainder received on October 10, 2025.

As additional consideration for the Second Forbearance Agreement and the Third Note, the Company agreed to issue the Lender 286,000 shares of its common stock for $286 (the “Commitment Shares”).

The information regarding this transaction was filed in a Current Report on Form 8-K filed with the Commission on October 14, 2025.

The Initial Note was satisfied in full on November 20, 2025 and the Third Note was satisfied in full on or about October 27, 2025, which left only the Second Note outstanding.

As previously reported, on February 5, 2026, the Company and the Lender entered into a fourth Forbearance, Note Payment and Registration Rights Amendment Agreement (the “Fourth Forbearance Agreement”), pursuant to which (a) the parties agreed that $5,995,722.21 was then outstanding, due and payable under the Second Note and (b) the Maturity Date of the Second Note was extended to as late as January 1, 2027, and (c) the Company agreed to pay the outstanding balance of the Second Note in the following installments, with payments, payable, at the option of the Company, either in cash or under certain conditions in Conversion Shares issued at the Default Conversion Price that are immediately salable by the Lender under Rule 144, as follows:

(i) $50,000 per week commencing Monday, April 6, 2026, (ii) $100,000 per week commencing Monday, July 6, 2026, (iii) $150,000 per week commencing Monday, October 5, 2026, and (iv) $250,000 per week commencing Monday, December 7, 2026, with the outstanding balance to be paid in full by January 1, 2027 (the “Amended Repayment Terms”).

The information regarding this transaction was filed in a Current Report on Form 8-K filed with the Commission on February 5, 2026.

As previously reported, on February 27, 2026, the Company and the Lender entered into a Third Amendment to Loan Agreement Fourth Forbearance Agreement and Registration Rights Agreement (the “Loan Agreement Amendment No.

3”) and $993,750 Original Principal Amount Junior Secured Promissory Note (the “Fourth Note”).

Under the terms of the Fourth Note the Lender agreed to loan us an additional $750,000, which matures on April 6, 2026.

In the event we default on the Fourth Note, the note begins accruing interest at 19% per annum, the principal amount due under the note is increased to 110% of the principal amount owed at the time of default, and the amounts due under the note become convertible with the Lender allowed to convert 200% of the amount due under the note at a conversion price equal to an 80% discount to the lesser of (a) the closing price of the Company’s common stock on (x) the Funding Date of the Initial Note and (y) the Funding Date of the Second Note (whichever closing price is lower), or (b) 20% of the closing price of the Company Common Stock on such applicable Funding Date.

Under the terms of the Loan Agreement Amendment No.

3, the Lender and Company agreed the date by which the Company has to relist on Nasdaq under the Fourth Forbearance Agreement was extended to April 6, 2026, and the Second Note default terms were amended in certain respects to the default terms in the Fourth Note.

The Company received the funds from the Fourth Note on February 27, 2026, minus $40,000 for legal and transaction fees.

The Company and the Lender also entered into a Subsidiary Guarantee, under which the Company’s subsidiaries are guaranteeing the amounts due under the Fourth Note (the “Subsidiary Guarantee”) and a Pledge and Security Agreement, under which the Company and its subsidiaries secured the repayment of the amounts due under the Second Note and the Fourth Note with their assets as collateral (the “Pledge and Security Agreement”).

Additionally, the Company conveyed certain real property and improvements it owns in Blaine County, Oklahoma to the Lender to secure the repayment of the Fourth Note.

In the event the Fourth Note is paid in full by the maturity date, the Oklahoma property will be reconveyed to the Company.

On May 6, 2026, the Company entered into a Forbearance and Note Payment Amendment Agreement (“May 2026 Forbearance Agreement”), under which the Lender agreed to forbear their rights under the Loan Agreement, as amended, if the Company agrees and complies with the following terms:

(i) the Company acknowledges that $6,815,805.71 adjusted outstanding balance is due and payable as of the Effective Date of the May 2026 Forbearance Agreement under the Second Note and $1,111,151.74 is outstanding, due and payable as of the Effective Date of this May 2026 Forbearance Agreement under the Fourth Note, (ii) the Company will pay Lender One Million Five Hundred Thousand Dollars ($1,500,000) upon the closing of the first funding of that certain financing transaction being conducted for the Company by RBW Capital Partners LLC, a division of Dawson James Securities, Inc.

(the “RBW Financing”), to occur on or before May 7, 2026, to be applied to the outstanding balance of the Second Note, (iii) the Company will pay Lender Two Million Five Hundred Thousand Dollars ($2,500,000) upon the second closing of the RBW Financing, to be applied to the outstanding balance of the Second Note, to occur upon the effectiveness of an S-1 Registration Statement, to be filed on or before May 13, 2026 and be effective on or before July 15, 2026, (iv) the remaining balance of the Second Note upon the earlier to occur of (a) closing of the transaction by and between the Company and Olenox Industries, Inc.

that is the subject of a Term Sheet dated January 27, 2026 (the “Olenox Transaction”) or (b) receipt by the Company of any proceeds from an Advance under the Standby Equity Purchase Agreement (the SEPA”) that is a component of the RBW Financing, with the first Advance to be on or before August 15, 2026, in which fifty percent (50%) of the net proceeds of each Advance shall be paid directly to the Lender until the Second Note is paid in full;

and (v) the outstanding balance of the Fourth Note upon the earlier to occur of (a) closing of the Olenox Transaction, (b) fifty percent (50%) of the net proceeds from an Advance under the SEPA that is a component of the RBW Financing, with the first Advance to occur on or before August 15, 2026 and so long as the Second Note has been repaid in full, on or before November 5, 2026.

Cedarview Forbearance Agreement

On May 6, 2026, the Company entered into a Forbearance Agreement (the “Cedarview Forbearance Agreement”) with Cedarview Opportunities Master Fund, LP (the “Investor”), under which the Investor agreed to forbear its rights under that certain Loan and Security Agreement (the “Cedarview Agreement”), dated February 5, 2024, the senior secured note to the Investor in an aggregate principal amount of $3,000,000 (the “Initial Note”), that certain Loan and Security Agreement, dated October 31, 2024, and a senior secured note to the Investor in an aggregate principal amount of $3,670,160.77 (the “Investor Second Note”, together with the Initial Note, the “Investor Notes”), as those documents have previously been amended, and the Investor agreed to extend the maturity date of the Initial Note and the Second Note to October 31, 2026, so long as the Company (i) make certain prepayments under the Existing Notes from the RBW SEPA or other financings, (ii) pays the Investor $250,000 from the second tranche of the RBW Financing, as a mandatory required prepayment of the Existing Notes, (iii) that if the Company closes the contemplated Olenox Transaction, by no later than the second (2nd) Business Day after such closing, the Company will pledge 2,000,000 shares of Olenox common stock the Company receives in the Olenox Transaction as additional collateral securing the Company’s payment obligations under the Existing Notes, in form and substance satisfactory to the Investor, in its sole discretion, and (iv) the Company issues the Investor 275,000 shares of its common stock, restricted in accordance with Rule 144 (the “Investor Shares”).

July 2026 Reverse Stock Split

On July 17, 2026, the Company effected a 1-for-20 reverse stock split of its common stock pursuant to a Certificate of Amendment to the Company’s Amended and Restated Articles of Incorporation following shareholder approval obtained at the Company’s Annual Meeting of Shareholders held on June 30, 2026.

March 2026 Reverse Stock Split

On March 24, 2026, the Company effected a 1-for-200 reverse stock split of its common stock pursuant to a Certificate of Amendment to the Company’s Amended and Restated Articles of Incorporation following shareholder approval obtained at the Company’s Special Meeting held on December 22, 2025.

Relisting On Nasdaq

On April 23, 2026, the Company received a letter (the “April Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Nasdaq Hearing Panel (the “Panel”) determined that the Company is in compliance with the Minimum Bid Price Requirement and that trading in the Company’s securities will resume trading on the Exchange effective April 27, 2026.

Pursuant to Listing Rule 5815(d)(4)(B), the Company will be subject to a Mandatory Panel Monitor for a period of one year from the date of the April Letter.

In the event that the Company becomes deficient with the Minimum Bid Price Requirement, the Company will not be afforded the opportunity to submit a compliance plan for the Staff’s consideration and the Staff will issue a Delisting Determination Letter, following which the Company may request review by the Panel, at which the Company may present a compliance plan for the Panel’s consideration.

Consulting Agreement

In May 2026, the Company entered into an Independent

Contractor Agreement with William Tuorto for consulting services he is performing for the Company dating back to April 1, 2026.

In connection

with the agreement, the Company issued 69,083 shares of common stock under the 2023 Plan, which shares were issued without a restrictive

legend pursuant to a Form S-8 registration statement.

Under the terms of the agreement, the consultant is Consultant responsible for assisting

in the management and operations related to the Company being a public company;

providing advice regarding the strategy of the Company

and its subsidiaries;

general advice regarding dispositions and/or acquisitions and negotiation assistance, which the Company believes

will be beneficial to it;

and any other consulting and project management services the Company may stand in need of as communicated in

writing (the “Services”).

In exchange for the Services, the Company agreed to pay the consultant $50,000 per month, with additional

fees due if the Company achieves certain EBITDA thresholds for the quarters ending June 30, 2026, September 30, 2026 and December 31,

The Company also agreed to pay the Consultant a $300,000 contract signing fee.

All fees owed to the Consultant are payable in shares

of the Company’s common stock, priced at the 52-week low closing price preceding the applicable calendar quarter, with such price

not subject to adjustment for stock splits, and payable out of any applicable equity incentive plan the Company has in place that has

been registered under Form S-8 so the shares may be issued without a restrictive legend.

Private Financing Transaction (the “Financing”)

May 2026 Private Financing Transaction (the “May 2026 Financing”)

Convertible Promissory Notes

The following summary of the Notes does not purport to be complete and is qualified in its entirety by reference to the forms of SPA and Notes filed as exhibits to the registration statement of which this prospectus forms a part.

On May 8, 2026, the

Company entered into a Securities Purchase Agreement (the “SPA”) with certain institutional investors (collectively, the

“Selling Stockholders”) providing for the issuance of convertible promissory notes (the “Notes”) with

aggregate gross proceeds to the Company of up to $12.0 million, before fees and expenses, in two closings.

The Notes have an

aggregate principal amount of $15.0 million, reflecting a $3.0 million original issue discount of 20%.

The following summary of the May 2026 Notes does not purport to be complete and is qualified in its entirety by reference to the forms of May 2026 SPA and May 2026 Notes filed as exhibits to a previously filed Current Report on Form 8-K.

On May 8, 2026, the Company entered into a Securities Purchase Agreement (the “MAY 2026 SPA”) with certain institutional investors (collectively, the “Selling Stockholder”) providing for the issuance of convertible promissory notes (the “May 2026 Notes”) with aggregate gross proceeds to the Company of up to $12.0 million, before fees and expenses, in two closings.

The May 2026 Notes have an aggregate principal amount of $15.0 million, reflecting a $3.0 million original issue discount of 20%.

The initial closing occurred on May 8, 2026, pursuant to which the Company received $6.0 million in gross proceeds.

A second closing for an additional $6.0 million remains subject to the effectiveness of the registration statement of which this prospectus forms a part and other customary closing conditions pursuant to the terms of the SPA and the Note.

The Notes are convertible into shares of the Company’s Common Stock at a conversion price equal to the greater of $0.37 per share and 80% of the lowest daily volume weighted average price (“VWAP”) of the Company’s common stock during the five trading days immediately preceding conversion.

Conversions under the Notes are generally subject to a 4.99% beneficial ownership limitation, which may be waived upon notice by the applicable holder.

The second closing for an additional $6.0 million closed on July 16, 2026.

Pursuant to the MAY 2026 SPA and the May 2026 Notes, the shares underlying the conversion of these two convertible promissory notes was registered on a Registration Statement on Form S-1 that went effective on July 16, 2026.

The May 2026 Notes are convertible into shares of the Company’s Common Stock at a conversion price equal to the greater of $0.37 per share and 80% of the lowest daily volume weighted average price (“VWAP”) of the Company’s common stock during the five trading days immediately preceding conversion.

On July 15, 2026, the Company and the Selling Stockholder entered into an Amendment No.

1 to the MAY 2026 SPA, May 2026 Notes and SEPA, under which the parties agreed the Selling Stockholder would fund the second closing in exchange for the Company agreeing the $0.37 floor price per share would not change as a result of the Company’s 1-for-20 reverse stock split that went effective on July 17, 2026.

Conversions under the May 2026 Notes are generally subject to a 4.99% beneficial ownership limitation, which may be waived upon notice by the applicable holder.

In addition, absent shareholder approval, conversions are limited to the extent necessary to comply with Nasdaq’s 19.99% issuance limitation.

The Notes contain customary events of default, including payment and covenant defaults, which may result in acceleration of amounts due under the notes and certain additional default-related remedies, including an increase in the outstanding principal amount upon the occurrence of certain events of default.

The Company agreed to register for resale shares issuable upon conversion of the Notes, and this prospectus forms part of the related registration statement.

The Company intends to use proceeds from the Financing for working capital, debt reduction, and general corporate purposes.

RBW Capital Partners LLC, a division of Dawson James Securities, Inc., acted as placement agent in connection with the Financing.

The May 2026 Notes contain customary events of default, including payment and covenant defaults, which may result in acceleration of amounts due under the notes and certain additional default-related remedies, including an increase in the outstanding principal amount upon the occurrence of certain events of default.

The Company is using the proceeds from the May 2026 Financing for working capital, debt reduction, and general corporate purposes.

RBW Capital Partners LLC, a division of Dawson James Securities, Inc., acted as placement agent in connection with the May 2026 Financing.

Standby Equity Purchase Agreement

The following summary of the Standby Equity Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the form of the Standby Equity Purchase Agreement filed as an exhibit to the registration statement of which this prospectus forms a part.

On May 8, 2026, the Company entered into a standby equity purchase agreement (the “SEPA”) with an institutional investor (the “SEPA Investor”) providing for the potential purchase by the SEPA Investor of up to $100 million of the Company’s common stock over a 36-month period, subject to the terms and conditions of the SEPA.

Under the SEPA, the Company may, at its discretion, direct the SEPA Investor to purchase shares of common stock from time to time, subject to specified volume limitations, pricing formulas, and beneficial ownership limitations set forth in the agreement.

On May 8, 2026, the Company entered into a standby equity purchase agreement (the “SEPA”) with an institutional investor (the “Selling Stockholder”) providing for the potential purchase by the Selling Stockholder of up to $100 million of the Company’s common stock over a 36-month period, subject to the terms and conditions of the SEPA.

Under the SEPA, the Company may, at its discretion, direct the Selling Stockholder to purchase shares of common stock from time to time, subject to specified volume limitations, pricing formulas, the number of shares registered under an effective registration statement and a 4.99% beneficial ownership limitation set forth in the agreement.

Shares issued under the SEPA will generally be purchased at a discount to prevailing market prices.

The Company controls the timing and amount of any sales under the SEPA, subject to the terms and limitations contained in the agreement.

The Company controls the timing and amount of any Company-directed sales under the SEPA, subject to the terms and limitations contained in the agreement;

however, while any promissory note issued to the Selling Stockholder remains outstanding, the Selling Stockholder may deliver an Investor Notice that is deemed to be a Purchase Notice and requires the Company to issue shares under the SEPA at the applicable conversion price.

Actual sales under the SEPA will depend on a variety of factors, including market conditions, trading prices of the Company’s common stock, and the Company’s capital needs.

The Company is required to file a separate registration statement covering shares issuable under the SEPA before any sales may occur under the agreement.

This summary is not a complete description of all of the terms of the related agreements and are qualified in their entirety by reference to the full text of the documents, forms of which are filed as exhibits hereto and/or incorporated by reference into this disclosure from prior filings.

In the event there are amounts due to the Selling Stockholder under any promissory note issued by the Company then the Selling Stockholder has the right to issue the Company an Investor Notice, which is deemed to be a Purchase Notice and requires the Company to issue the Selling Stockholder shares of Common Stock under the SEPA at the applicable conversion price in the relevant promissory note.

The Company will not receive any cash proceeds from an Investor Notice but will receive a reduction in the amounts owed under the applicable promissory note.

The Company is required to file a separate registration statement covering 270,270,271 shares issuable under the SEPA, which must be declared effective by the SEC before any sales may occur under the agreement.

The 270,270,271 shares being registered for issuance under the SEPA represent the maximum number of shares issuable under the Equity Line, including shares that may be issued pursuant to Company-directed Advances and Investor Notices.

Cedarview Forbearance Agreement

Relisting On Nasdaq

Pursuant to Listing Rule 5815(d)(4)(B), the Company will be subject to a Mandatory Panel Monitor for a period of one year from the date of the April Letter.

Consulting Agreement

In May 2026, the Company entered into an Independent Contractor Agreement with William Tuorto for consulting services he is performing for the Company dating back to April 1, 2026.

In connection with the agreement, the Company issued 3,455 shares of common stock under the 2023 Plan, which shares were issued without a restrictive legend pursuant to a Form S-8 registration statement.

Under the terms of the agreement, the consultant is Consultant responsible for assisting in the management and operations related to the Company being a public company;

providing advice regarding the strategy of the Company and its subsidiaries;

general advice regarding dispositions and/or acquisitions and negotiation assistance, which the Company believes will be beneficial to it;

and any other consulting and project management services the Company may stand in need of as communicated in writing (the “Services”).

In exchange for the Services, the Company agreed to pay the consultant $50,000 per month, with additional fees due if the Company achieves certain EBITDA thresholds for the quarters ending June 30, 2026, September 30, 2026 and December 31, 2026.

The Company also agreed to pay the Consultant a $300,000 contract signing fee.

All fees owed to the Consultant are payable in shares of the Company’s common stock, priced at the 52-week low closing price preceding the applicable calendar quarter, with such price not subject to adjustment for stock splits, and payable out of any applicable equity incentive plan the Company has in place that has been registered under Form S-8 so the shares may be issued without a restrictive legend.

EXHIBIT INDEX

8 unchanged sentences

Certificate of Amendment to Amended and Restated Articles of Incorporation to Effect 1-for-200 Reverse Stock Split

Certificate of Amendment to Amended and Restated Articles of Incorporation to Effect 1 -for- 20 Reverse Stock Split

Vivakor, Inc.

13 unchanged sentences

Security Agreement dated February 5, 2024, between Vivakor, Inc., and Cedarview Opportunities Master Fund LP

Exhibit Description

Form of Parent Voting and Support Agreement re Empire Merger Agreement

5 unchanged sentences

Form of First Amended and Restated Master Netting Agreement re Endeavor MIPA

Exhibit Description

Convertible Promissory Note dated March 29, 2024 with Keke Mingo

24 unchanged sentences

Pledge Agreement dated October 31, 2024, by and among Vivakor, Inc., each of Vivakor, Inc.’s subsidiaries party thereto and Cedarview Capital Management, LLC, as agent for the lenders

Exhibit Description

Guaranty dated October 31, 2024, by and among certain subsidiaries of Vivakor, Inc.

2 unchanged sentences

Purchase and Sale Agreement by and between Pilot OFS Holdings, LLC and Meridian Equipment Leasing, LLC dated December 22, 2023

Exhibit Description

Letter Agreement regarding Secured Promissory Note and related Loan Documents by and between Pilot OFS and Meridian Equipment Leasing, LLC dated October 1, 2024

14 unchanged sentences

Business Manager Agreement by and between b1Bank and Endeavor Crude, LLC dated January 6, 2023

Exhibit Description

Loan and Security Agreement by and between B1Bank and Meridian Equipment Leasing, LLC, et al dated November 12, 2020

1 unchanged sentence

Trucking Transport Agreement Addendum by and between Endeavor Crude, LLC and White Claw Crude, LLC dated January 1, 2024

Exhibit Description

First Amendment to Crude Oil Gathering and Dedication Agreement by and between CPE Midcon Gathering, LLC and Continental Resources, Inc.

24 unchanged sentences

Transition Agreement dated August 3, 2025, by and between Vivakor, Inc., Vivakor Administration, LLC, and Russ M.

Exhibit Description

Second Amended Employment Agreement, by and between Vivakor, Inc., Vivakor Administration, LLC and Les Patterson, dated August 12, 2025

5 unchanged sentences

Form of Physical Commodity Intermediation Agreement dated October 22, 2025

Exhibit Description

Settlement Agreement with James Samuelson dated October 23, 2025

19 unchanged sentences

Consulting Agreement with William Tuorto dated May 2026

Amendment No.

1 to Debt Satisfaction and Preferred Stock Amendment Agreement

Amendment No.

1 to Securities Purchase Agreement, Convertible Notes and SEPA dated July 15, 2026

Subsidiaries of the Company

9 unchanged sentences

1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit Description

Inline XBRL Instance Document

12 unchanged sentences

Chief Executive Officer (Principal Executive Officer)

August 19, 2026

VIVAKOR, INC.

2 unchanged sentences

Chief Financial Officer (Principal Financial and Accounting Officer)

August 19, 2026

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information